Global Anastomosis Devices Market, By Type (Disposable, Reusable), By Application, and By Region - Trends and Forecast Analysis, 2021-2035

Global Anastomosis Devices Market Size is expected to reach USD 12.26 Billion by 2035 from USD 3.83 Billion in 2024, with a CAGR of around 11.15% between 2024 and 2035. The global anastomosis devices market is experiencing growth driven by advancements in surgical techniques and an aging population. Minimally invasive procedures, such as laparoscopic and robotic-assisted surgeries, are increasingly being adopted due to their benefits, including smaller incisions, reduced trauma, and faster recovery times. For example, the introduction of robotic surgical staplers equipped with software ensures uniformity in sutures, enhancing surgical outcomes. Additionally, the rising number of elderly individuals worldwide is leading to a higher prevalence of age-related diseases, thereby increasing the demand for surgical interventions. However, the market faces challenges, notably the high cost of advanced anastomosis devices. The development and production of these devices involve significant investments in research and development, leading to higher prices that may limit accessibility, especially in developing regions. Despite these challenges, opportunities exist in the development of bioabsorbable anastomosis devices, which can reduce the risk of complications associated with permanent implants. Moreover, the expansion of healthcare infrastructure in emerging economies presents a significant growth opportunity. Countries like India and South Korea are witnessing improvements in medical facilities and an increase in surgical procedures, driving the demand for anastomosis devices. These factors collectively contribute to the evolving landscape of the global anastomosis devices market.

Driver: Minimally Invasive Surgeries Fuel Growth

The increasing adoption of minimally invasive surgeries has been a significant driver for the growth of the anastomosis devices market. These techniques involve smaller incisions, reduced blood loss, and faster recovery times, making them an attractive option for both surgeons and patients. Anastomosis devices, such as staplers and suturing tools, are essential for joining tissues or blood vessels during these procedures. Robotic-assisted surgeries, for instance, allow surgeons to perform highly precise tissue connections with minimal disruption to surrounding areas. Real-life examples include the use of staplers in laparoscopic colorectal surgeries, where surgeons rely on advanced devices like circular staplers to join the colon ends after removing a section. These devices enable faster recovery and reduced hospital stays for patients. Another example is the use of robotic surgery in coronary artery bypass grafting (CABG), where anastomosis devices are employed to join arteries with precision in confined spaces, reducing the need for large incisions. As hospitals and surgical centers continue to adopt these advanced technologies, the demand for anastomosis devices rises. Patients benefit from reduced trauma, less postoperative pain, and quicker healing times, while healthcare providers see better surgical outcomes and shorter recovery periods, driving the overall growth in the market for these specialized devices.

Key Insights:

• The adoption rate of disposable anastomosis devices reached 86.4% in 2023, reflecting strong preference for single-use products.

• Cardiovascular surgery accounts for 52% of the total anastomosis devices application market share as of 2023.

• Hospitals represent 75% of end-users for anastomosis devices, highlighting their dominant role in surgical procedures.

• North America holds 40% of the global anastomosis devices market share, driven by advanced healthcare infrastructure.

• Approximately 40 to 50 million major surgeries are performed annually in the U.S., many requiring anastomosis devices.

• Johnson & Johnson and other key companies invested over $50 million collectively in R&D for advanced anastomosis technologies in 2023.

• The global market saw sales of over 15 million anastomosis devices units in 2023 across all applications.

• Asia-Pacific is the fastest-growing region with an adoption growth rate exceeding 7% annually due to rising healthcare expenditure.

Segment Analysis:

The anastomosis devices market is segmented into disposable and reusable types, with each having specific advantages based on the surgical needs. Disposable anastomosis devices, such as single-use staplers and sutures, are gaining popularity due to their convenience and reduced risk of cross-contamination. These devices are often used in high-turnover environments like emergency rooms and outpatient clinics, where fast, efficient procedures are necessary. On the other hand, reusable devices are typically more durable and cost-effective in the long term. Hospitals and surgical centers may invest in high-quality reusable staplers for routine surgeries, ensuring long-term reliability and sustainability. Reusable devices are often preferred for complex surgeries where precision and consistent performance are crucial. In terms of application, cardiovascular surgery and gastrointestinal surgery are the primary fields where anastomosis devices are essential. In cardiovascular surgeries, devices like vascular staplers are commonly used to connect blood vessels during coronary artery bypass grafting (CABG) or aortic aneurysm repair. For gastrointestinal surgeries, staplers are used extensively in procedures like colectomies or gastric bypass surgeries to join sections of the digestive tract. As surgical techniques evolve, the demand for both disposable and reusable anastomosis devices is expected to rise, driven by advancements in minimally invasive and robotic-assisted surgeries.

Regional Analysis:

The global anastomosis devices market is expanding across all regions, each experiencing unique growth patterns. In North America, advanced healthcare infrastructure and the high prevalence of cardiovascular diseases are driving the demand for anastomosis devices. Hospitals in the U.S. frequently use devices like vascular staplers in coronary bypass surgeries. In Europe, an increasing preference for minimally invasive surgeries is fueling market growth. The U.K. and Germany are adopting advanced anastomosis devices for both gastrointestinal and cardiovascular surgeries, with robotic-assisted surgeries becoming more common in these regions. Asia Pacific is experiencing rapid growth due to the expanding healthcare sector in countries like China and India. Surgeons in these regions are increasingly using anastomosis devices in gastrointestinal surgeries like colon resection, driven by both the aging population and rising healthcare standards. In the Middle East, the rise in private healthcare facilities and medical tourism is propelling demand. Countries like the UAE are incorporating high-tech anastomosis devices in surgeries, making them accessible to international patients. Latin America, though at a smaller scale, is showing promise with countries like Brazil investing in state-of-the-art surgical equipment for cardiovascular surgeries. Across all regions, an increasing focus on patient safety, better surgical outcomes, and quicker recovery times continues to drive the adoption of these devices.

Competitive Scenario:

The anastomosis devices market is experiencing significant advancements, driven by technological innovations and strategic collaborations. In March 2024, Getinge announced FDA 510(k) clearance for the Vasoview Hemopro 3, an endoscopic vessel harvesting system designed to enhance procedural efficiency in cardiovascular surgeries. This development underscores the industry's commitment to improving patient outcomes through advanced technology. Similarly, in November 2024, GI Windows Surgical secured USD 37 million in funding to advance the clinical development and commercialization of its innovative Flexagon self-forming magnet technology. This cutting-edge system leverages magnetic anastomosis to facilitate less invasive surgical procedures, aiming to transform tissue fusion and delivery systems in anastomosis technology. Furthermore, in September 2024, GT Metabolic Solutions achieved FDA de novo clearance for its MagDI system, a first-generation device designed for side-to-side duodeno-ileal anastomosis. The MagDI system employs magnetic compression anastomosis to eliminate the need for bowel incisions, minimize procedural variability, and avoid leaving foreign materials in the body during minimally invasive surgeries. These developments highlight the ongoing efforts within the industry to enhance surgical precision, reduce patient recovery times, and minimize complications. As the market continues to evolve, such innovations are expected to play a pivotal role in shaping the future of anastomosis devices, catering to the growing demand for safer and more efficient surgical solutions.

Anastomosis Devices Market Report Scope

The Global Anastomosis Devices Market report is segmented as follows:

By Type,

• Disposable
• Reusable

By Application,

• Cardiovascular Surgery
• Gastrointestinal Surgery

By Region,

• North America
• U.S.
• Canada
• Mexico
• Europe
• UK
• Germany
• France
• Spain
• Italy
• Russia
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Southeast Asia
• Rest of Asia Pacific
• Latin America
• Brazil
• Argentina
• Rest of Latin America
• Middle East & Africa
• Saudi Arabia
• UAE
• South Africa
• Rest of Middle East and Africa

Key Market Players,

• Medtronic(US)
• LivaNova PLC(UK)
• Maquet Holding B.V. & Co(Sweden)
• Vitalitec International Inc(France)
• Dextera Surgical Inc(US)
• Synovis Micro Alliance Inc(US)
• Ethicon LLC(US)

Research Objectives

• Proliferation and maturation of trade in the global Anastomosis Devices Market.
• The market share of the global Anastomosis Devices Market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Anastomosis Devices Market.
• Feasibility study, new market insights, company profiles, investment return, market size of the global Anastomosis Devices Market.